Synthetic Studies on Cyathin Terpenoids
FULL PAPER
1034 cm–1. 1H NMR (400 MHz, CDCl3): δ = 5.89 (s, 1 H, 9-H),
for the MS spectra and Mrs. S. Mairesse-Lebrun for the elemental
4.17 (d, J = 11.5 Hz, 1 H, CH2OCOtBu), 4.01 (d, J = 11.5 Hz, 1 analyses.
H, CH2OCOtBu), 2.81 [hept, J = 6.8 Hz, 1 H, CH(CH3)2], 2.64
(ddd, J = 11.8, 5.6, 2.1 Hz, 1 H, 7-Hβ), 2.45–2.30 (m, 3 H, 2-H, 7-
Hα), 2.10 (ddd, J = 11.8, 5.4, 2.1 Hz, 1 H, 6-Hβ), 1.85–1.78 (m, 3
H, 6-Hα, 5-H, 3-H), 1.75–1.60 (m, 4 H, 4-H, 5-H, 3-H), 1.21 [s, 9
H, OCOC(CH3)3], 1.03 [d, J = 6.8 Hz, 3 H, CH(CH3)2], 1.01 [s, 3
H, C(CH3)], 0.96 [d, J = 6.8 Hz, 3 H, CH(CH3)2] ppm. 13C NMR
(100 MHz, CDCl3): δ = 199.1 (C, CO), 178.0 [C, OCOC(CH3)3],
157.9 (C, C9a), 149.2 (C, C1), 136.8 (C, C9b), 127.2 (CH, C9), 64.0
(CH2, CH2OCOtBu), 49.5 (C, C3a), 40.3 (C, C5a), 39.2 (CH2, C3),
38.8 [C, OCOC(CH3)3], 36.1 (CH2, C4), 34.0 (CH2, C7), 33.4 (CH2,
C6), 32.6 (CH2, C5), 29.2 (CH2, C2), 27.2 [3 CH3, OCOC(CH3)3],
26.9 [CH, (CH3)2CH], 23.8 [CH3, C(CH3)], 21.3 [CH3, (CH3)2CH],
21.2 [CH3, (CH3)2CH] ppm. MS (EI = 70 eV), m/z (%): 358 (49)
[M·+], 343 (17), 271 (14), 259 (43), 257 (100). C23H34O3 (358.5):
calcd. C 77.05, H 9.56; found C 76.71, H 9.79.
[1] a) A. D. Allbutt, W. A. Ayer, H. J. Brodie, B. N. Johri, H.
Taube, Can. J. Microbiol. 1971, 1401–1407; b) W. A. Ayer, H.
Taube, Tetrahedron Lett. 1972, 1917–1920; c) W. A. Ayer, H.
Taube, Can. J. Chem. 1973, 51, 3842 –3854; d) W. A. Ayer,
L. L. Carstens, Can. J. Chem. 1973, 51, 3157–3160; e) W. A.
Ayer, L. M. Browne, J. R. Mercer, D. R. Taylor, D. E. Ward,
Can. J. Chem. 1978, 56, 717–721; f) W. A. Ayer, T. Yoshida,
D. M. J. van Schie, Can. J. Chem. 1978, 56, 2113–2120; g) W. A.
Ayer, T. T. Nakashima, D. E. Ward, Can. J. Chem. 1978, 56,
2197–2199; h) H.-J. Hecht, G. Höfle, W. Steglich, T. Anke, F.
Oberwinkler, J. Chem. Soc., Chem. Commun. 1978, 665–666; i)
D. Green, I. Goldberg, Z. Stein, M. Ilan, Y. Kashman, Nat.
Prod. Lett. 1992, 4, 193–199.
[2] a) H. Kawagishi, A. Shimada, R. Shirai, K. Okamoto, F.
Ojima, H. Sakamoto, Y. Ishiguro, S. Furakawa, Tetrahedron
Lett. 1994, 35, 1569–1572; b) H. Kawagishi, A. Shimada, K.
Shizuki, H. Mori, K. Okamoto, H. Sakamoto, S. Furukawa,
Heterocycl. Commun. 1996, 2, 51–54; c) H. Kawagishi, A. Shi-
mada, S. Hosakawa, H. Mori, H. Sakamoto, Y. Ishiguro, S.
Sakemi, J. Bordner, N. Kojima, S. Furukawa, Tetrahedron Lett.
1996, 37, 7399–7402.
[3] a) T. Ohta, T. Kita, N. Kobayashi, Y. Obara, N. Nakahata, Y.
Ohizumi, Y. Takaya, Y. Oshima, Tetrahedron Lett. 1998, 39,
6229–6232; b) T. Kita, Y. Takaya, Y. Oshima, T. Ohta, K. Aiz-
awa, T. Hirano, T. Inakuma, Tetrahedron 1998, 54, 11877–
11886; c) Y. Obara, N. Nakahata, T. Kita, Y. Takaya, H. Ko-
bayashi, S. Hosoi, F. Kiuchi, T. Ohta, Y. Oshima, Y. Ohizumi,
Eur. J. Pharmacol. 1999, 370, 79–84.
[4] H. Shibata, T. Tokunaga, D. Karasawa, A. Hirota, M. Nakay-
ama, H. Nozaki, T. Tada, Agric. Biol. Chem. 1989, 53, 3373–
3375.
[5] Y. Obara, H. Kobayashi, T. Ohta, Y. Ohizumi, N. Nakahata,
Mol. Pharmacol. 2001, 59, 1287–1297.
[6] a) S. Carswell, Exp. Neurol. 1993, 124, 36–42; b) S. S. Riaz,
D. R. Tomlinson, Prog. Neurobiol. 1996, 49, 125–143; c) J. M.
Conner, M. H. Tuszynski, Ment. Retard Dev. Dis. 1998, 4, 212–
222; d) D. Kirik, B. Georgievska, A. Bjorklund, Nat. Neurosci.
2004, 7, 105–110.
[7] S. J. Pollack, S. J. Harper, Curr. Drug Targets CNS & Neurol.
Disord. 2002, 1, 59–80.
(3aR,5aR)-[1-Isopropyl-3a-methyl-8-oxo-3,3a,4,5,6,7,8,9-octahydro-
cyclohepta[e]inden-5a(2H)-yl]methyl 2,2-Dimethylpropanoate (5): A
solution of Me3Al (2 in heptane, 0.5 mL, 1 mmol) was added to
dry CH2Cl2 (6 mL). The mixture was cooled to –78 °C and a solu-
tion of dienone 52 (80 mg, 0.22 mmol) in dry CH2Cl2 (2 mL) was
added followed by a solution of TMSCHN2 (2 in hexane, 0.5 mL,
1 mmol). The reaction mixture was warmed to room temperature
for 4 h. After diluting with CH2Cl2 (20 mL), an ice-cooled aqueous
solution of NaHCO3 (3 mL) was slowly added at 0 °C and stirring
was continued for 5 min. The organic layer was separated and the
aqueous phase extracted with diethyl ether (2×10 mL). The com-
bined organic phases were dried with MgSO4 and concentrated in
vacuo. The residue was dissolved in acetone (3 mL) and 3 HCl
(1.5 mL) was added. The mixture was stirred for 2 h at room tem-
perature. Solid K2CO3 (330 mg, 2.4 mmol) was then added and the
mixture was concentrated under reduce pressure. The residue was
extracted with diethyl ether (2×10 mL). The combined organic
phases were dried with MgSO4 and concentrated in vacuo. Purifica-
tion by silica gel chromatography (cyclohexane/ethyl acetate, 10:1)
gave ketone 5 as colourless oil (50 mg, 60% yield) and 54 (8 mg,
10% yield). Only the major isomer 5 is described. [α]2D0 = +225 (c
= 0.8, EtOH). IR (film): ν = 2957, 2934, 2865, 1727 (C=O, OC-
˜
1
OtBu), 1667 (C=C), 1479, 1458, 1397, 1281, 1150 cm–1. H NMR
[8] a) B. B. Snider, N. H. Vo, S. V. O’Neil, B. M. Foxman, J. Am.
Chem. Soc. 1996, 118, 7644–7645; b) B. B. Snider, N. H. Vo,
S. V. O’Neil, J. Org. Chem. 1998, 63, 4732–4740.
(400 MHz, CDCl3) δ = 5.30 (t, J = 6.5 Hz, 1 H, 10-H), 3.97 (d, J
= 11.2 Hz, 1 H, CH2OCOtBu), 3.93 (d, J = 11.2 Hz, 1 H, CH2OC-
OtBu), 3.48 (dd, J = 14.4, 6.2 Hz, 1 H, 9-H), 3.18 (dd, J = 14.4,
6.7 Hz, 1 H, 9-H), 2.73 [hept, J = 6.8 Hz, 1 H, CH(CH3)2], 2.69
(ddd, J = 18.8, 9.8, 2.7 Hz, 1 H, 7-H), 2.52 (ddd, J = 18.8, 8.9,
2.3 Hz, 1 H, 7-H), 2.35–2.25 (m, 3 H, 2-H, 6-H), 1.95–1.85 (m, 1
H, 4-Hax), 1.80–1.50 (m, 5 H, 6-H, 3-H, 5-H), 1.38 (dt, J = 13.8,
3.3 Hz, 1 H, 4-Heq), 1.19 [s, 9 H, OCOC(CH3)3], 0.94 [d, J =
6.8 Hz, 3 H, CH(CH3)2], 0.92 [s, 3 H, C(CH3)], 0.90 [d, J = 6.8 Hz,
3 H, CH(CH3)2] ppm. 13C NMR (100 MHz, CDCl3) δ = 209.2 (C,
CO), 178.2 [C, OCOC(CH3)3], 142.3 (C, C10b), 139.9 (C, C1 or
C10a), 139.7 (C, C1 or C10a), 117.8 (CH, C10), 66.8 (CH2, CH2O-
COtBu), 48.7 (C, C3a), 44.8 (C, C5a), 41.6 (CH2, C9), 38.9 [C,
OCOC(CH3)3], 38.7 (CH2, C3), 37.9 (CH2, C7), 36.4 (CH2, C5),
31.7 (CH2, C4), 30.6 (CH2, C6), 28.4 (CH2, C2), 27.2 [3 CH3, OC-
OC(CH3)3], 26.4 [CH, (CH3)2CH], 23.4 [CH3, C(CH3)], 21.6 [CH3,
(CH3)2CH], 21.3 [CH3, (CH3)2CH] ppm. C24H36O3 (372.5): calcd.
C 77.38, H 9.74; found C 77.15, H 9.84.
[9] M. Tori, N. Toyoda, M. Sono, J. Org. Chem. 1998, 63, 306–
313.
[10] E. Piers, M. Gilbert, K. L. Cook, Org. Lett. 2000, 2, 1407–
1410.
[11] a) W. A. Ayer, D. E. Ward, L. M. Browne, L. T. J. Delbaere, Y.
Hoyano, Can. J. Chem. 1981, 59, 2665–2672; b) D. E. Ward,
Can. J. Chem. 1987, 65, 2380–2384; c) D. E. Ward, Y. Gai, Q.
Qiao, Org. Lett. 2000, 2, 2125–2127; d) D. E. Ward, Y. Gai, Q.
Qiao, J. Shen, Can. J. Chem. 2004, 82, 254–267.
[12] M. Takano, A. Umino, M. Nakada, Org. Lett. 2004, 6, 4897–
4900.
[13] B. M. Trost, L. Dong, G. M. Schroeder, J. Am. Chem. Soc.
2005, 127, 2844–2845.
[14] S. P. Waters, Y. Tian, Y.-M. Li, S. J. Danishefsky, J. Am. Chem.
Soc. 2005, 127, 13514–13515.
[15] For a review see: a) D. L. Wright, C. R. Whitehead, Org. Prep.
Proced. Int. 2000, 32, 307–330. For more recent approaches
see; b) K. Takeda, D. Nakane, M. Takeda, Org. Lett. 2000, 2,
1903–1905; c) P. A. Wender, F. C. Bi, M. A. Brodney, F.
Gosselin, Org. Lett. 2001, 3, 2105–2108.
[16] a) C. Thominiaux, A. Chiaroni, D. Desmaële, Tetrahedron Lett.
2002, 43, 4107–4110; b) E. Drège, G. Morgant, D. Desmaële,
Tetrahedron Lett. 2005, 46, 7263–7266.
Acknowledgments
We gratefully acknowledge Dr. Jacqueline Mahuteau and Dr.
Michèle Ourevitch for the NMR experiments, Mrs Michèle Danet
Eur. J. Org. Chem. 2006, 4825–4840
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4839